37 related articles for article (PubMed ID: 7690315)
1. Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors.
Cooper MH; Gregory SH; Starzl TE; Wing EJ
Transplantation; 1994 Feb; 57(3):433-9. PubMed ID: 7509089
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of tacrolimus (FK506) for the treatment of allergic diseases.
Kandikattu HK; Mishra A
Int J Cell Biol Physiol; 2018; 1(1-2):5-13. PubMed ID: 31595270
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.
Zeevi A; Duquesnoy R; Eiras G; Rabinowich H; Todo S; Makowka L; Starzl TE
Transplant Proc; 1988 Feb; 20(1 suppl 1):220-222. PubMed ID: 21307965
[No Abstract] [Full Text] [Related]
4. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
[TBL] [Abstract][Full Text] [Related]
5. Protein Translation and Signaling in Human Eosinophils.
Esnault S; Shen ZJ; Malter JS
Front Med (Lausanne); 2017; 4():150. PubMed ID: 28971096
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical effects of rapamycin on experimental house dust mite-induced asthma.
Fredriksson K; Fielhaber JA; Lam JK; Yao X; Meyer KS; Keeran KJ; Zywicke GJ; Qu X; Yu ZX; Moss J; Kristof AS; Levine SJ
PLoS One; 2012; 7(5):e33984. PubMed ID: 22685525
[TBL] [Abstract][Full Text] [Related]
7. Pimecrolimus reduces eosinophil activation associated with calcium mobilization.
Plager DA; Henke SA; Matsuwaki Y; Madaan A; Squillace DL; Dierkhising RA; Kita H
Int Arch Allergy Immunol; 2009; 149(2):119-26. PubMed ID: 19127068
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase.
Palframan RT; Collins PD; Severs NJ; Rothery S; Williams TJ; Rankin SM
J Exp Med; 1998 Nov; 188(9):1621-32. PubMed ID: 9802974
[TBL] [Abstract][Full Text] [Related]
9. Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.
Sehgal SN
Ther Drug Monit; 1995 Dec; 17(6):660-5. PubMed ID: 8588237
[TBL] [Abstract][Full Text] [Related]
10. Immunopharmacology of rapamycin.
Abraham RT; Wiederrecht GJ
Annu Rev Immunol; 1996; 14():483-510. PubMed ID: 8717522
[TBL] [Abstract][Full Text] [Related]
11. FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils.
Hom JT; Estridge T
Clin Immunol Immunopathol; 1993 Sep; 68(3):293-300. PubMed ID: 7690315
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists.
Hatfield SM; Mynderse JS; Roehm NW
J Pharmacol Exp Ther; 1992 Jun; 261(3):970-6. PubMed ID: 1376361
[TBL] [Abstract][Full Text] [Related]
13. FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA.
Hanke JH; Nichols LN; Coon ME
Lymphokine Cytokine Res; 1992 Oct; 11(5):221-31. PubMed ID: 1281674
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine and FK506 inhibition of murine mast cell cytokine production.
Hatfield SM; Roehm NW
J Pharmacol Exp Ther; 1992 Feb; 260(2):680-8. PubMed ID: 1371158
[TBL] [Abstract][Full Text] [Related]
15. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
Sano T; Nakamura Y; Matsunaga Y; Takahashi T; Azuma M; Okano Y; Shimizu E; Ogushi F; Sone S; Ogura T
Eur Respir J; 1995 Sep; 8(9):1473-8. PubMed ID: 8575571
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
